Evidence map›Paper›PMID 31980637›Full record

ArticleNature communications2020

Programmable meroterpene synthesis.

Xingyu Shen, Chi P Ting, Gong Xu, Thomas J Maimone

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Enantioselective Total Synthesis of (+)-Garsubellin A.Angewandte Chemie (International ed. in English) · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xingyu Shen *Department of Chemistry, University of California, Berkeley, 826 Latimer Hall, Berkeley, CA, 94702, USA.
Chi P Ting *Department of Chemistry, University of California, Berkeley, 826 Latimer Hall, Berkeley, CA, 94702, USA.ORCID http://orcid.org/0000-0003-1386-1902
Gong XuDepartment of Chemistry, University of California, Berkeley, 826 Latimer Hall, Berkeley, CA, 94702, USA.ORCID http://orcid.org/0000-0002-4305-4370
Thomas J MaimoneDepartment of Chemistry, University of California, Berkeley, 826 Latimer Hall, Berkeley, CA, 94702, USA. maimone@berkeley.edu.ORCID http://orcid.org/0000-0001-5823-692X

Funding

A proposal for the purchase of a new Cu anode Microsource X-ray Diffractometer wiS10RR027172 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAYMOND, KENNETH N · 2010 to 2010
$500k
Acquisition of a Cryoprobe and Related Accessories for a 600 MHz NMR Spectrometer to Support Health Research Activities at the University of California, BerkeleyS10OD024998 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARTWIG, JOHN F · 2018 to 2018
$265k
NCRR NIH HHS S10 RR027172NIH HHS S10 OD024998
6 · The paper itself

Abstract

The bicyclo[3.3.1]nonane architecture is a privileged structural motif found in over 1000 natural products with relevance to neurodegenerative disease, bacterial and parasitic infection, and cancer among others. Despite disparate biosynthetic machinery, alkaloid, terpene, and polyketide-producing organisms have all evolved pathways to incorporate this carbocyclic ring system. Natural products of mixed polyketide/terpenoid origins (meroterpenes) are a particularly rich and important source of biologically active bicyclo[3.3.1]nonane-containing molecules. Herein we detail a fully synthetic strategy toward this broad family of targets based on an abiotic annulation/rearrangement strategy resulting in a 10-step total synthesis of garsubellin A, an enhancer of choline acetyltransferase and member of the large family of polycyclic polyprenylated acylphloroglucinols. This work solidifies a strategy for making multiple, diverse meroterpene chemotypes in a programmable assembly process involving a minimal number of chemical transformations.

Indexed as

Biosynthetic PathwaysMonoterpenesOxidation-ReductionStereoisomerismTerpenesgarsubellin AMonoterpenesTerpenes

Identifiers

PMID31980637
PMCPMC6981159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.